Pierrette Seeldrayers

Author

Also Known As

L. Rumbach, Myriam Schluep, P Seeldrayers, P. A. Seeldrayers, P. Seeldrayers, PIERRETTE A. SEELDRAYERS, Pierrette A. Seeldrayers, Pierrette Seeldrayers, Sandra Vukusic

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Grand Charleroi Hospital Erasmus Hospital Brigham and Women's Hospital Cliniques Universitaires Saint-Luc Universitair Ziekenhuis Brussel

About

Pierrette Seeldrayers is an author at Grand Charleroi Hospital specializing in medicine, neurology, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.6K
2	Public Health	3	3	133
3	Social Sciences	1	1	37
4	Allergy	1	1	35
5	Allergy Medicine	1	1	35

Pierrette Seeldrayers

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study Giancarlo Comi, Massimo Filippi, Frederik Barkhof, The Lancet Autoimmune DiseaseNeurological DisorderImmunologyClinical TrialsClinical Neurology	2001	1.1K
Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging Hans‐Peter Hartung, Karlheinz Reiners, Juan J. Archelos, Annals of Neurology	1995	151
The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation David Johnson, Pierrette Seeldrayers, Howard L. Weiner Brain Research NeuroregenerationMyelin ProteinsMedicineMast Cell DisorderImmunology	1988	105
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS Robert J. Fox, Andrew Chan, Ralf Gold, Neurology Clinical Practice	2016	104
Soluble ICAM‐1 serum levels in multiple sclerosis and viral encephalitis Hans‐Peter Hartung, M. Michels, Karlheinz Reiners, Neurology Autoimmune DiseaseMedicineImmunologyImmune RegulationAdhesion Molecule	1993	74
Multiple sclerosis registries in Europe – An updated mapping survey Anna Glaser, Alexander Stahmann, Peter Flachenecker, Multiple Sclerosis and Related Disorders Neurological DisorderClinical EpidemiologyInternational HealthNeurologyPrevalence	2018	64
An Analysis of Mast Cell Frequency in the Rodent Nervous System: Numbers Vary between Different Strains and Can Be Reconstituted in Mast Cell-Deficient Mice David Johnson, Dag H. Yasui, Pierrette Seeldrayers Journal of Neuropathology & Experimental Neurology	1991	57
Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon β in relapsing- remitting Multiple Sclerosis (ASIIMS) trial R Gonsette, Christian Sindic, Marie D’hooghe, Multiple Sclerosis Journal	2010	56
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis Dirk De Ridder, Frank Van der Aa, Jan Debruyne, Clinical Neurology and Neurosurgery UrologyNeurological DisorderClinical NeurologyUrogynecologyNeurology	2013	55
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study Peter Joseph Jongen, Dirk Lehnick, E. A. C. M. Sanders, Health and Quality of Life Outcomes	2010	50

Page 1